Antiviral profiles of novel iminocyclitol compounds against bovine viral diarrhea virus, West Nile virus, dengue virus and hepatitis B virus

Antiviral Chemistry and Chemotherapy

Volumn 18, Issue 1, 2007, Pages 49-59

  Gu, Baohua ^a   Mason, Peter ^b   Wang, Lijuan ^a   Norton, Pamela ^a   Bourne, Nigel ^b   Moriarty, Robert ^c   Mehta, Anand ^a   Despande, Mehendra ^d   Shah, Rajendra ^d   Block, Timothy ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d OrgSyn Laboratory Inc   (United States)

Author keywords

Bovine viral diarrhea virus; Dengue virus; Deoxynojirimycin; Hepatitis B virus; West Nile virus

Indexed keywords

ALKYL GROUP; DEOXYNOJIRIMYCIN; GENE PRODUCT; GLYCAN; GLYCOPROTEIN; IMINOCYCLITOL DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; BOVINE DIARRHEA VIRUS; CONTROLLED STUDY; CYTOTOXICITY; DENGUE VIRUS; ENDOPLASMIC RETICULUM; ENZYME INHIBITION; HEPATITIS B VIRUS; IMMUNOASSAY; IN VITRO STUDY; MORPHOGENESIS; NONHUMAN; OXYGENATION; PRIORITY JOURNAL; STRUCTURE ANALYSIS; VIRUS INHIBITION; WEST NILE FLAVIVIRUS;

EID: 33947216518     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020701800105     Document Type: Article

References (28)

1. Bergeron JJ, Brenner MB, Thomas DY & Williams DB (1994). Calnexin: a membrane-bound chaperone of the endoplasmic reticulum. Trends in Biochemical Sciences 19:124-128.
2. Block TM & Jordan R (2001). Iminosugars as possible broad spectrum anti hepatitis virus agents: the glucovirs and alkovirs. Antiviral Chemistry and Chemotherapy 12:317-325.
3. Block TM, Lu X, Platt FM, Foster GR, Gerlich WH, Blumberg BS & Dwek RA (1994). Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin. Proceedings of the National Academy of Sciences of the United States of America 91:2235-2239.
4. Chapel C, Garcia C, Roingeard P, Zitzmann N, Dubuisson J, Dwek RA, Trepo C, Zoulim F & Durantel D (2006). Antiviral effect of alpha-glucosidase inhibitors on viral morphogenesis and binding properties of hepatitis C virus-like particles. Journal of General Virology 87:861-871.
5. Durantel D, Branza-Nichita N, Carrouee-Durantel S, Butters TD, Dwek RA & Zitzmann N (2001). Study of the mechanism of antiviral action of iminosugar derivatives against bovine viral diarrhea mas. Journal of Virology 75:8987-8998.
6. Ellgaard L, Molinari M & Helenius A (1999). Setting the standards: quality control in the secretory pathway. Science 286:1882-1888.
7. Gentry M K, Henchal EA, McCown JM, Brandt WE & Dalrymple JM (1982). Identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies. American Journal of Tropical Medicine and Hygiene 31:548-55.
8. Gu B, Liu C, Lin-Goerke J, Maley DR, Gutshall LL, Feltenberger CA & Del Vecchio AM (2000). The RNA helicase and nucleotide triphosphatase activities of the bovine viral diarrhea virus NS3 protein are essential for viral replication. Journal of Virology 74:1794-1800.
9. Gu B, Ouzunov S, Wang L, Mason P, Bourne N, Cuconati A & Block TM (2006). Discovery of small molecule inhibitors of West Nile virus using a high-throughput sub-genomic replicon screen. Antiviral Research 70:39-50.
10. Helenius A & Aebi M (2004). Roles of N-linked glycans in the endoplasmic reticulum. Annual Review of Biochemistry 73:1019-1049.
11. Jordan R, Nikolaeva OV, Wang L, Conyers B, Mehta A, Dwek RA & Block TM (2002). Inhibition of host ER glucosidase activity prevents Golgi processing of virion-associated bovine viral diarrhea virus E2 glycoproteins and reduces infectivity of secreted virions. Virology 295:10-19.
12. Mackenzie JM & Westaway EG (2001). Assembly and maturation of the flavivirus Kunjin virus appear to occur in the rough endoplasmic reticulum and along the secretory pathway, respectively. Journal of Virology 75:10787-10799.
13. Mehta A, Carrouee S, Conyers B, Jordan R, Butters T, Dwek RA & Block TM (2001). Inhibition of hepatitis B virus DNA replication by imino sugars without the inhibition of the DNA polymerase: therapeutic implications. Hepatology 33:1488-1495.
14. Mehta A, Conyers B, Tyrrell DL, Walters KA, Tipples GA, Dwek RA & Block TM (2002a). Structure-activity relationship of a new class of anti-hepatitis B virus agents. Antimicrobial Agents and Chemotherapy 46:4004-4008.
15. Mehta A, Lu X, Block TM, Blumberg BS & Dwek RA (1997). Hepatitis B virus (HBV) envelope glycoproteins vary drastically in their sensitivity to glycan processing: evidence that alteration of a single N-linked glycosylation site can regulate HBV secretion. Proceedings of the National Academy of Sciences of the United States of America 94:1822-1827.
16. Mehta A, Ouzounov S, Jordan R, Simsek E, Lu X, Moriarty RM, Jacob G, Dwek RA & Block TM (2002b). Imino sugars that are less toxic but more potent as antivirals, in vitro, compared with N-n-nonyl DNJ. Antiviral Chemistry and Chemotherapy 13:299-304.
17. Mehta AS, Gu B, Conyers B, Ouzounov S, Wang L, Moriarty RM, Dwek RA & Block TM (2004). alpha-Galactosylceramide and novel synthetic glycolipids directly induce the innate host defense pathway and have direct activity against hepatitis B and C viruses. Antimicrobial Agents and Chemotherapy 48:2085-2090.
18. Norton PA, Conyers B, Gong Q, Steel LF, Block TM & Mehta AS (2005). Assays for glucosidase inhibitors with potential antiviral activities: secreted alkaline phosphatase as a surrogate marker. Journal of Virological Methods 124:167-172.
19. Ou WJ, Cameron PH, Thomas DY & Bergeron JJ (1993). Association of folding intermediates of glycoproteins with calnexin during protein maturation. Nature 364:771-776.
20. Ouzounov S, Mehta A, Dwek RA, Block TM & Jordan R (2002). The combination of interferon alpha-2b and n-butyl deoxynojirimycin has a greater than additive antiviral effect upon production of infectious bovine viral diarrhea virus (BVDV) in vitro: implications for hepatitis C virus (HCV) therapy. Antiviral Research 55:425-435.
21. Rossi SL, Zhao Q, O'Donnell VK & Mason PW (2005). Adaptation of West Nile virus replicons to cells in culture and use of replicon-bearing cells to probe antiviral action. Virology 331:457-470.
22. Sells MA, Chen ML & Acs G (1987). Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proceedings of the National Academy of Sciences of the United States of America 84:1005-1009.
23. Simsek E, Mehta A, Zhou T, Dwek RA & Block TM (2005). Hepatitis B virus large and middle glycoproteins are degraded by a proteasome pathway in glucosidase-inhibited cells but not in cells with functional glucosidase enzyme. Journal of Virology 79:12914-12920.
24. Tan A, van den Broek L, Bolscher J, Vermaas DJ, Pastoors L, van Boeckel C & Ploegh H (1994). Introduction of oxygen into the alkyl chain of N-decyl-dNM decreases lipophilicity and results in increased retention of glucose residues on N-linked oligosaccharides. Glycobiology 4:141-149.
25. Tan A, van den Broek L, van Boeckel S, Ploegh H & Bolscher J (1991). Chemical modification of the glucosidase inhibitor 1-deoxynojirimycin. Structure-activity relationships. Journal of Biological Chemistry 266:14504-14510.
26. Wu SF, Lee CJ, Liao CL, Dwek RA, Zitzmann N & Lin YL (2002). Antiviral effects of an iminosugar derivative on flavivirus infections. Journal of Virology 76:3596-3604.
27. Zitzmann N, Mehta AS, Carrouee S, Butters TD, Platt FM, McCauley J, Blumberg B. S., Dwek RA & Block TM (1999). Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents. Proceedings of the National Academy of Sciences of the United States of America 96:11878-11882.
28. Whitby, K, Pierson, TC, Geiss, B, Lane, K, Engle, M, Zhou, Y, Doms, RW and Diamond, MS (2005). Castanospermine, a potent inhibitor of dengue virus infection in vitro and in vivo. Journal of Virology 79:8698-8706.